Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Accenture (ACN) Stock Jumps on OpenAI Deal: AI Pivot, Earnings Date and Wall Street Targets as of December 2, 2025

Accenture (ACN) Stock Jumps on OpenAI Deal: AI Pivot, Earnings Date and Wall Street Targets as of December 2, 2025

Accenture shares closed at $261 on December 2, 2025, up after announcing a partnership with OpenAI and confirming Q1 FY26 earnings for December 18. The stock remains about 34% below its 52-week high despite fiscal 2025 revenue rising 7% to $69.7 billion and free cash flow hitting $10.9 billion. Accenture pays an annual dividend of $6.52 per share, yielding 2.3–2.6%.
Super Micro Computer (SMCI) Stock in December 2025: Can the AI Server Star Rebound After a Brutal Sell‑Off?

Super Micro Computer (SMCI) Stock in December 2025: Can the AI Server Star Rebound After a Brutal Sell‑Off?

Super Micro Computer (SMCI) closed at $32.9 on December 2, down nearly 37% in November and over 50% from its 52-week high. The company missed fiscal Q1 2026 estimates with $5.0 billion in revenue and a 9.3% gross margin, its lowest in years. Analyst targets imply upside, but consensus remains “Hold.” Heavy insider selling and volatile trading persist amid competition and delayed AI server deliveries.
Amgen (AMGN) Stock Today: Earnings Momentum, Obesity Breakthroughs and Fresh December 2, 2025 Forecasts

Amgen (AMGN) Stock Today: Earnings Momentum, Obesity Breakthroughs and Fresh December 2, 2025 Forecasts

Amgen shares traded at $338.67 on December 2, 2025, up 0.35% and near 52-week highs after strong Q3 results and a raised 2025 outlook. Several institutional investors disclosed reduced AMGN holdings in Q2 filings. Technical analysts flagged a short-term bullish setup. The company’s obesity and cardiovascular drugs remain key pipeline drivers.
Cipher Mining (CIFR) Stock Today: JPMorgan Upgrade, Big Tech AI Deals, and the 2025–2026 Outlook

Cipher Mining (CIFR) Stock Today: JPMorgan Upgrade, Big Tech AI Deals, and the 2025–2026 Outlook

Cipher Mining (CIFR) shares fell 8% to around $18 Tuesday after recent highs, despite a 194% gain over the past year. JPMorgan upgraded the stock to “Overweight” with an $18 target, citing major AI data-center deals with AWS and Fluidstack/Google. Q3 revenue jumped 197% to $72 million, but the company posted a $3 million GAAP net loss. The stock remains volatile amid insider selling and analyst debate.
NXP Semiconductors (NXPI) Surges on AI and Auto Rebound: Latest News, Forecasts and Stock Outlook as of December 2, 2025

NXP Semiconductors (NXPI) Surges on AI and Auto Rebound: Latest News, Forecasts and Stock Outlook as of December 2, 2025

NXP Semiconductors shares surged over 8% to $216–$218 Tuesday afternoon, ranking among the top S&P 500 gainers. The rally follows Q3 revenue of $3.17 billion, slightly above estimates but down 2% year-over-year. Technical indicators show strong momentum, with RSI near 90. The stock remains about 15% below its 52-week high of $255.
Seagate Technology (STX) Stock Surges 220% in 2025 as Citi Lifts Target to $320 – Is There Still Upside?

Seagate Technology (STX) Stock Surges 220% in 2025 as Citi Lifts Target to $320 – Is There Still Upside?

Seagate shares closed at $268.79 on December 2, 2025, up more than 170% over the past year. Citigroup raised its price target to $320, citing strong AI-driven demand for high-capacity drives. Cantor Fitzgerald and Loop Capital also lifted targets, with Loop now at $465. Insider sales reached about $34 million last quarter, while institutional ownership is near 93%.
2 December 2025
Rigetti Computing (RGTI) Stock on December 2, 2025: Price, Quantum Roadmap, Analyst Targets and Key Risks

Rigetti Computing (RGTI) Stock on December 2, 2025: Price, Quantum Roadmap, Analyst Targets and Key Risks

Rigetti Computing shares traded at $23.98 late on December 2, up 2% after heavy losses in November wiped out much of its 2025 rally. The stock has swung between $2.40 and $58.15 over the past year and now carries a market cap near $8 billion, despite 2024 revenue of just $10.8 million. Trading volume topped 20 million shares. AI models expect continued volatility and label the stock high risk.
Datadog (DDOG) Stock Today: AI Agent Launch, Q3 Earnings Momentum and Wall Street Forecasts — 2 December 2025

Datadog (DDOG) Stock Today: AI Agent Launch, Q3 Earnings Momentum and Wall Street Forecasts — 2 December 2025

Datadog launched Bits AI SRE, its first general-availability AI incident-response agent, on December 2, 2025. Shares traded near $156.5 midday, down less than 1%, with a market cap around $56.2 billion. The company reported slim GAAP profit margins but strong cash flow, and its stock remains well below its 52-week high of $201.69.
IonQ Stock (IONQ) in December 2025: Latest News, Analyst Forecasts, and Quantum Computing Risks Investors Need to Know

IonQ Stock (IONQ) in December 2025: Latest News, Analyst Forecasts, and Quantum Computing Risks Investors Need to Know

IonQ shares traded around $47.68 on December 2, 2025, with heavy volume and a 52-week range of $17.88 to $84.64. The stock remains up roughly 90% year-over-year but is down about 45% from its 2025 peak after dilution concerns and a sector pullback. IonQ reported $40 million in Q3 revenue and $1.3 billion in net losses for the first three quarters. Market cap stands near $17.5 billion.
ServiceNow (NOW) Stock on Watch: Veza Deal, AI Partnerships and Stock Split Vote Shape December 2025 Outlook

ServiceNow (NOW) Stock on Watch: Veza Deal, AI Partnerships and Stock Split Vote Shape December 2025 Outlook

ServiceNow said Tuesday it will acquire identity security firm Veza, expanding its security and AI offerings. Shares traded near $829, down over 30% from the 52-week high, with a market cap of about $169 billion. The company’s price-to-earnings ratio stands at 98.5, well above industry averages. Financial terms of the Veza deal were not disclosed.
2 December 2025
Lam Research (LRCX) Jumps on Morgan Stanley Upgrade: Is the AI Wafer-Equipment Rally Running Hot or Just Getting Started?

Lam Research (LRCX) Jumps on Morgan Stanley Upgrade: Is the AI Wafer-Equipment Rally Running Hot or Just Getting Started?

Lam Research shares rose about 2% to $158 Tuesday after Morgan Stanley raised its price target to $158, maintaining an “Equal-Weight” rating. The stock has more than doubled in 2025, reaching a market cap near $200 billion. Short interest and cautious options activity have increased. Analyst targets now cluster near current prices, with few outright bearish calls.
2 December 2025
Hut 8 Corp (HUT) Stock Slumps Over 10% as Bitcoin Miners Crack — Is the AI and Power Play Still Worth the Risk?

Hut 8 Corp (HUT) Stock Slumps Over 10% as Bitcoin Miners Crack — Is the AI and Power Play Still Worth the Risk?

Hut 8 shares fell over 10% to around $39 on December 2, 2025, amid a sharp sell-off in Bitcoin mining stocks as Bitcoin dropped below $84,000. Trading volume topped $430 million. Despite the decline, Hut 8 remains up nearly 99% year-to-date, with a 52-week range of $10.04 to $57.29. Wall Street analysts remain bullish, but legal and valuation concerns persist.
Ondas Holdings (ONDS) Stock Jumps on Drone Defense Deals and $425M War Chest – Latest News, Forecast and Analysis (2 December 2025)

Ondas Holdings (ONDS) Stock Jumps on Drone Defense Deals and $425M War Chest – Latest News, Forecast and Analysis (2 December 2025)

Ondas Holdings shares jumped about 10% Tuesday to $8.34 after record Q3 results, a $425 million equity raise, and major drone tech acquisitions. The stock has soared 824% over the past year, with 2025 revenue guidance raised to at least $36 million. Q3 revenue hit $10.1 million, up 582% year-over-year, while net loss narrowed to $7.5 million. Cash on hand totaled $433.4 million at quarter-end.
United Airlines (UAL) Stock Jumps on Travelport Deal and Bullish Analyst Targets – Is the 2026 Rally Already Boarding?

United Airlines (UAL) Stock Jumps on Travelport Deal and Bullish Analyst Targets – Is the 2026 Rally Already Boarding?

United Airlines shares rose about 4% to $105 on December 2 after announcing a multi-year partnership with Travelport and receiving a credit rating upgrade. Wall Street firms reaffirmed Buy ratings, with average 12-month price targets near $125–127. The company’s market cap stands at $33.2 billion. Analysts project 2026 EPS at $13.10, with the stock trading at about 8 times that estimate.
2 December 2025
Qualcomm (QCOM) Stock Today: AI Push, Dividend Deadline and 2026 Forecast – December 2, 2025

Qualcomm (QCOM) Stock Today: AI Push, Dividend Deadline and 2026 Forecast – December 2, 2025

Qualcomm shares traded at $169–170 Tuesday, valuing the company near $181 billion. Fiscal Q4 2025 revenue rose 10% to $11.27 billion, with adjusted EPS up 12% to $3.00, both beating estimates. Automotive and IoT segments grew 17% and 7% year-on-year. The company guided Q1 FY2026 revenue above consensus at $11.8–$12.6 billion.
MercadoLibre Stock Today: MELI Rebounds as Fintech Growth, New Partnerships and Analyst Targets Point to 2026 Re‑Rating

MercadoLibre Stock Today: MELI Rebounds as Fintech Growth, New Partnerships and Analyst Targets Point to 2026 Re‑Rating

MercadoLibre shares rose over 4% to $2,149 on December 2, 2025, rebounding from recent lows but still 19% below their 52-week high. Q3 revenue climbed 39% to $7.4 billion, but net profit and margins missed forecasts. The company’s market cap stands near $109 billion, with a P/E around 52. Analysts’ price targets average $2,850, implying significant upside.
2 December 2025
1 771 772 773 774 775 811

Stock Market Today

  • Siren Exits Ascendis Pharma with $50 Million Sale Amid Strong Quarterly Performance
    May 14, 2026, 3:43 PM EDT. On May 14, 2026, investment fund Siren sold its entire stake in Ascendis Pharma A/S, offloading 235,862 shares in a $52.87 million transaction based on first-quarter average prices. The divestment reduced Siren's position by approximately $50.3 million, including sales and market price effects. Despite this exit, Ascendis shares have risen 50% over the past year, outperforming the S&P 500 by 24 percentage points. The Danish biopharma company recently reported robust Q1 results, with revenue doubling to 247 million euros driven by sales of YORVIPATH and SKYTROFA, and recorded a net profit boosted by a deferred tax asset. Ascendis focuses on rare endocrine and pediatric diseases using its TransCon technology. Siren's sale does not signal a negative outlook amid Ascendis' strong momentum and expanding rare disease patient base.

Latest articles

REGENXBIO Stock Plunges as Duchenne Gene Therapy Win Runs Into Safety Questions

REGENXBIO Stock Plunges as Duchenne Gene Therapy Win Runs Into Safety Questions

14 May 2026
REGENXBIO shares fell 37% to $6.31 after its Duchenne muscular dystrophy gene therapy, RGX-202, met the main goal in a late-stage trial. Investors reacted to two serious adverse events and uncertainty over FDA approval. The company reported 93% of patients showed microdystrophin expression at 12 weeks. REGENXBIO said it will seek accelerated approval and targets a 2027 launch.
Digi Power X Stock Slides Before Earnings as $1.1 Billion AI Deal Faces First Test

Digi Power X Stock Slides Before Earnings as $1.1 Billion AI Deal Faces First Test

14 May 2026
Digi Power X shares fell 14% to $7.28 in heavy trading Thursday ahead of its first-quarter results and operations update due May 15. Investors are focused on its $1.1 billion, 10-year AI data-center deal with Cerebras and a $19.6 million SubQ AI GPU rental contract launching Friday. The company also expanded its at-the-market share-sale program to $175 million.
Smart Powerr Stock Nearly Quadruples as Nasdaq Delisting Threat Shadows CREG

Smart Powerr Stock Nearly Quadruples as Nasdaq Delisting Threat Shadows CREG

14 May 2026
Smart Powerr shares jumped to 78.83 cents, up nearly 59 cents from the previous close, after hitting 90.37 cents intraday. The surge followed news that Nasdaq warned the company over its sub-$1 share price and possible suspension. Trading volume reached about 395 million shares. The company said a hearing request would delay any suspension but gave no assurance of keeping its Nasdaq listing.
Go toTop